PROPANC BIOPHARMA, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-4.5M | $-4.5M | $9.9K | $1.7M |
| FY2017 | $-2.1M | $-2.1M | — | $1.7M |
| FY2018 | $-2.2M | $-2.2M | — | $516.1K |
| FY2019 | $-2.1M | $-2.1M | $2.9K | — |
| FY2020 | $-1.8M | $-1.8M | — | $300.4K |
| FY2021 | $-1.1M | $-1.1M | — | $82.9K |
| FY2022 | $-1.4M | $-1.4M | — | $72.5K |
| FY2023 | $-1.1M | $-1.1M | — | $2.4K |
| FY2024 | $-935.1K | $-935.1K | — | — |
| FY2025 | $-405.2K | $-405.2K | — | $4.6M |